Xiangyi Kong

Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing

Xiaopei Hao, Zhiying Zheng, Hanyuan Liu et al. · Redox Biology · 2022 · 303 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial

Yongxiang Xia, Weiwei Tang, Xiaofeng Qian et al. · Journal for ImmunoTherapy of Cancer · 2022 · 211 citations · Full text

Medicine, Oncology, Pharmacology +17

Microglia and macrophage exhibit attenuated inflammatory response and ferroptosis resistance after RSL3 stimulation via increasing Nrf2 expression

Yu Cui, Zhaolong Zhang, Xin Zhou et al. · Journal of Neuroinflammation · 2021 · 201 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer

Xiangyi Kong, Yihang Qi, Xiangyu Wang et al. · Progress in Materials Science · 2023 · 147 citations

Pharmacy, Oncology, Pharmaceutics +16

Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator

Li Chen, Ping Bai, Xiangyi Kong et al. · Frontiers in Cell and Developmental Biology · 2021 · 128 citations · Full text

Agriculture, Nutrition, Oncology +17